It is noteworthy that two of the genes that were found to predict poor survival of prostate and breast cancer patients in the present study (PTTG1 and COL1A2), form part of a 17-gene signature associated with metastases [15]. The gene discussed is COL1A2; the disease is breast carcinoma.